Vismodegib

본문 바로가기


Home > Product > Vismodegib
Selling leads
Vismodegib
Posting date : Jun 30, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Vismodegib, trade name: Erivedge; It is one of the new anti-tumor drugs for the treatment of advanced cutaneous basal cell carcinoma (BCC), which was applied for and developed by Genentech Co., Ltd. and was approved for marketing by the US Food and Drug Administration (FDA) on January 30, 2012. Since October 2012, Erivedge has been approved by the European Union, Switzerland, Australia, Israel, South Korea, Mexico and Ecuador.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2025 ECROBOT.COM. All rights reserved.
Top